Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Zemel

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Blood Purification|January 1, 1996
Cytokine patterns in the effluent of continuous ambulatory peritoneal dialysis: relationship to peritoneal permeabilityD Zemel, R T Krediet
Blood Purification|January 1, 1993
Fibronectin during CAPD-related peritonitis: no indications for intraperitoneal productionD Zemel, G C Koomen, D G Struijk, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1995
Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPDD Zemel, M G Betjes, C Dinkla, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1991
Day-to-day variability of protein transport used as a method for analyzing peritoneal permeability in CAPDD Zemel, R T Krediet, G C Koomen, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1991
Individual characterization of the peritoneal restriction barrier to macromoleculesR T Krediet, D Zemel, D G Struijk, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 1, 1995
Dialysate markers of peritoneal tissue during peritonitis and in stable CAPDM M Pannekeet, D Zemel, G C Koomen, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1994
Cancer antigen 125 is locally produced in the peritoneal cavity during continuous ambulatory peritoneal dialysisG C Koomen, M G Betjes, D Zemel, et al.
Blood Purification|January 1, 1994
Clinical significance and detection of individual differences and changes in transperitoneal transportR T Krediet, A L Imholz, D Zemel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 29, 2001
Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPDC E Douma, D R de Waart, D Zemel, et al.
Clinical Nephrology|February 1, 1992
Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membraneD Zemel, R J ten Berge, D G Struijk, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Blood Purification|January 1, 1996
Cytokine patterns in the effluent of continuous ambulatory peritoneal dialysis: relationship to peritoneal permeabilityD Zemel, R T Krediet
Blood Purification|January 1, 1993
Fibronectin during CAPD-related peritonitis: no indications for intraperitoneal productionD Zemel, G C Koomen, D G Struijk, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1995
Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPDD Zemel, M G Betjes, C Dinkla, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1991
Day-to-day variability of protein transport used as a method for analyzing peritoneal permeability in CAPDD Zemel, R T Krediet, G C Koomen, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1991
Individual characterization of the peritoneal restriction barrier to macromoleculesR T Krediet, D Zemel, D G Struijk, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 1, 1995
Dialysate markers of peritoneal tissue during peritonitis and in stable CAPDM M Pannekeet, D Zemel, G C Koomen, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1994
Cancer antigen 125 is locally produced in the peritoneal cavity during continuous ambulatory peritoneal dialysisG C Koomen, M G Betjes, D Zemel, et al.
Blood Purification|January 1, 1994
Clinical significance and detection of individual differences and changes in transperitoneal transportR T Krediet, A L Imholz, D Zemel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 29, 2001
Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPDC E Douma, D R de Waart, D Zemel, et al.
Clinical Nephrology|February 1, 1992
Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membraneD Zemel, R J ten Berge, D G Struijk, et al.
Pageof 3